Oncocyte corp (OCX)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
ASSETS
CURRENT ASSETS
Cash and cash equivalents

16,577

22,072

19,444

35,826

39,257

8,034

10,821

10,294

12,612

7,600

11,024

8,644

11,352

10,174

12,674

4,000

5,856

7,996

Accounts receivable

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable equity securities

325

379

415

518

606

428

830

728

-

760

-

-

-

-

-

-

-

-

Marketable equity securities

-

-

-

-

-

-

-

-

950

-

-

-

-

-

-

-

-

-

Available-for-sale securities, at fair value (Note 2)

-

-

-

-

-

-

-

-

-

-

1,003

1,113

1,649

2,237

2,417

1,617

1,779

2,541

Prepaid expenses and other current assets

1,224

505

418

720

1,130

180

245

382

492

168

457

512

451

285

191

129

262

388

Total current assets

18,139

22,956

20,277

37,064

40,993

8,642

11,896

11,404

14,054

8,528

12,484

10,269

13,452

12,696

15,282

5,746

7,897

10,925

NONCURRENT ASSETS
Right-of-use assets, machinery and equipment, net

4,298

3,728

-

-

-

614

-

-

-

-

-

-

-

-

-

-

-

-

Equity method investment in Razor

10,635

10,964

11,245

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

9,187

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangibles, net

15,075

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Machinery, equipment and right of use assets, net

-

-

1,079

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

0

0

686

746

807

867

927

988

1,049

1,109

1,169

1,230

Machinery and equipment, net

-

-

-

413

486

-

722

615

722

822

833

895

636

688

475

515

581

576

Deposits and other noncurrent assets

2,169

2,211

169

189

198

262

287

-

-

120

-

-

-

-

-

-

-

-

Deposits

-

-

-

-

-

-

-

177

120

-

125

110

159

75

54

54

-

0

TOTAL ASSETS

59,503

39,859

32,770

37,666

41,677

9,518

12,905

12,196

15,582

10,216

14,249

12,141

15,174

14,447

16,860

7,424

9,647

12,731

LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Amount due to Lineage and affiliates

-

6

-

5

-

2,101

2,110

2,100

2,105

2,099

2,102

2,540

2,610

2,854

2,105

1,688

1,318

807

Accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

1,498

1,316

-

797

669

509

879

1,182

Amount due to affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

151

151

-

40

Amount due to affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

152

-

Accounts payable

1,635

469

358

556

136

166

194

232

307

175

-

-

211

422

870

192

403

285

Accrued expenses and other current liabilities

3,420

2,610

1,855

2,486

1,957

2,109

1,044

1,043

1,909

1,042

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

1,193

-

-

-

-

-

Loan payable, current

1,500

1,125

577

769

800

800

800

800

800

800

733

533

333

0

-

-

-

-

Right-of-use and financing lease liabilities, current

373

230

-

-

-

385

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease and right of use liabilities, current

-

-

253

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liability, current

-

-

-

245

304

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease liability, current

-

-

-

-

-

-

471

310

346

338

304

297

202

202

173

173

-

0

Total current liabilities

6,928

4,440

3,043

4,061

3,197

5,561

4,619

4,485

5,467

4,454

4,637

4,686

4,549

4,275

3,968

2,713

2,752

2,314

NONCURRENT LIABILITIES
Loan payable, net of deferred financing costs, noncurrent

1,565

1,905

-

-

159

347

531

713

893

1,070

1,243

1,416

1,589

0

-

-

-

-

Financing lease and right of use liabilities, noncurrent

3,097

2,676

-

-

-

187

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration liabilities

11,130

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

158

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease and right of use liabilities, noncurrent

-

-

392

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liability, noncurrent

-

-

-

100

134

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease liability, noncurrent

-

-

-

-

-

-

232

152

200

289

321

400

263

310

211

244

-

0

TOTAL LIABILITIES

22,878

9,021

3,435

4,161

3,490

6,095

5,382

5,350

6,560

5,813

6,201

6,502

6,401

4,585

4,179

2,957

2,752

2,314

Commitments and contingencies (Note 13)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

SHAREHOLDERS' EQUITY
Preferred stock, no par value, 5,000 shares authorized; none issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

Common stock, no par value, 85,000 shares authorized; 62,484 and 57,032 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

138,102

124,583

115,126

114,071

113,370

74,742

74,343

70,695

68,366

59,968

59,410

49,985

49,360

45,818

45,354

35,345

35,069

34,901

Accumulated other comprehensive loss

-

-

-

-

-

-

0

0

0

-888

-645

-535

-581

-654

-474

-1,273

-1,112

-350

Accumulated deficit

-101,477

-93,745

-85,791

-80,566

-75,183

-71,319

-66,820

-63,849

-59,344

-54,677

-50,717

-43,811

-40,006

-35,302

-32,199

-29,605

-27,062

-24,134

Total shareholders' equity

36,625

30,838

29,335

33,505

38,187

3,423

7,523

6,846

9,022

4,403

8,048

5,639

8,773

9,862

12,681

4,467

6,895

10,417

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

59,503

39,859

32,770

37,666

41,677

9,518

12,905

12,196

15,582

10,216

14,249

12,141

15,174

14,447

16,860

7,424

9,647

12,731